Omalizumab with allergen immunotherapy in respiratory & food allergy
{{output}}
Allergen Immunotherapy (AIT) is the only disease modifying treatment option for patient with IgE mediated allergic disorder. Conventional subcutaneous immunotherapy is associated with adverse events during build-up and maintenance phase but cluster allergen im... ...